An Open Label, Prospective Parallel Cohort Study Comparing A 90-day Copaxone Adherence Enhancement Program Among Persons With Multiple Sclerosis Who Participate in Shared Solutions Alone or in Partnership With Their MS Center

Trial Profile

An Open Label, Prospective Parallel Cohort Study Comparing A 90-day Copaxone Adherence Enhancement Program Among Persons With Multiple Sclerosis Who Participate in Shared Solutions Alone or in Partnership With Their MS Center

Completed
Phase of Trial: Phase IV

Latest Information Update: 13 Apr 2011

At a glance

  • Drugs Glatiramer acetate (Primary)
  • Indications Multiple sclerosis
  • Focus Therapeutic Use
  • Sponsors Teva Neuroscience
  • Most Recent Events

    • 13 Apr 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top